期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Texosome-based drug delivery system for cancer therapy: from past to present 被引量:2
1
作者 Hamideh Mahmoodzadeh Hosseini Raheleh Halabian +1 位作者 mohsen amin Abbas Ali Imani Fooladi 《Cancer Biology & Medicine》 SCIE CAS CSCD 2015年第3期150-162,共13页
Rising worldwide cancer incidence and resistance to current anti-cancer drugs necessitate the need for new pharmaceutical compounds and drug delivery system. Malfunction of the immune system, particularly in the tumor... Rising worldwide cancer incidence and resistance to current anti-cancer drugs necessitate the need for new pharmaceutical compounds and drug delivery system. Malfunction of the immune system, particularly in the tumor microenvironment, causes tumor growth and enhances tumor progression. Thus, cancer immunotherapy can be an appropriate approach to provoke the systemic immune system to combat tumor expansion. Texosomesj which are endogenous nanovesicles released by all tumor cells, contribute to cell-cell communication and modify the phenotypic features of recipient cells due to the texosomes' ability to transport biological components. For this reason, texosome-based delivery system can be a valuable strategy for therapeutic purposes. To improve the pharmaceutical behavior of this system and to facilitate its use in medical applications, biotechnology approaches and mimetic techniques have been utilized. In this review, we present the development history oftexosome-based delivery systems and discuss the advantages and disadvantages of each system. 展开更多
关键词 Cancer therapy texosome mimetic tumor microenvironment IMMUNOTHERAPY
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部